A manual of human physiology, including histology and microscopical anatomy, with special reference to the requirements of practical medicine by Dr. L. Landois ... Tr. from the 4th German ed. With additions by William Stirling ...

v. 1

An introduction to the study of the Protozoa, with special reference to the parasitic forms. By E. A. Minchin.

1922

Enhancing text classification to improve information filtering

Text classification, information filtering, semi-supervised learning, quality control

Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure

Background: Matrix metalloproteinases (MMPs) are a family of enzymes important for the resorption of extracellular matrices, control of vascular remodeling and repair. Increased activity of MMP2 has been demonstrated in heart failure, and in acutely decompensated heart failure (ADHF) a decrease in circulating MMPs has been demonstrated along with successful treatment. Objective: Our aim was to test the influence of spironolactone in MMP2 levels. Methods: Secondary analysis of a prospective, interventional study including 100 patients with ADHF. Fifty patients were non-randomly assigned to spironolactone (100 mg/day) plus standard ADHF therapy (spironolactone group) or standard ADHF therapy alone (control group). Results: Spironolactone group patients were younger and had lower creatinine and urea levels (all p < 0.05). Baseline MMP2, NT-pro BNP and weight did not differ between spironolactone and control groups. A trend towards a more pronounced decrease in MMP2 from baseline to day 3 was observed in the spironolactone group (-21 [-50 to 19] vs 1.5 [-26 to 38] ng/mL, p = 0.06). NT-pro BNP and weight also had a greater decrease in the spironolactone group. The proportion of patients with a decrease in MMP2 levels from baseline to day 3 was also likely to be greater in the spironolactone group (50% vs 66.7%), but without statistical significance. Correlations between MMP2, NT-pro BNP and weight variation were not statistically significant. Conclusion: MMP2 levels are increased in ADHF. Patients treated with spironolactone may have a greater reduction in MMP2 levels.

Biomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve Disease and Special Situations

Cardiovascular diseases are the main causes of mortality and morbidity in Brazil. Their primary and secondary preventions are a priority for the health system and require multiple approaches for increased effectiveness. Biomarkers are tools used to identify with greater accuracy high-risk individuals, establish a faster diagnosis, guide treatment, and determine prognosis. This review aims to highlight the importance of biomarkers in clinical cardiology practice and raise relevant points regarding their application and perspectives for the next few years. This document was divided into two parts. This second part addresses the application of biomarkers in coronary heart disease, valvular diseases, cardio-oncology, pulmonary embolism, and cardiorenal syndrome.

Special bulletin / Smithsonian Institution, United States National Museum.

no. 2 (1895)

The zoölogy of the lakes Amatitlan and Atitlan, Guatemala, with special reference to ichthyology.

v.7:no.6(1908)

American spiders and their spinningwork. A natural history of the orbweaving spiders of the United States, with special regard to their industry and habits. By Henry C. McCook.

v.1 1889

Evolution of neotropical cricetine rodents (Muridae) with special reference to the phyllotine group.

v.46(1962)

Larval life in the leaves: arboreal tadpole types, with special attention to the morphology, ecology, and behavior of the Oophagous Osteopilus brunneus (Hylidae) larva / Michael J. Lannoo, Daniel S. Townsend, Richard J. Wassersug.

n.s. no.38(1987)

The Indian tribes of the Chicago region, with special reference to the Illinois and the Potawatomi / by William Duncan Strong -- Former Assistant Curator of North American Ethnology and Archaeology. 8 plates.

no.24(1926)